PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial

PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial

Abstract Background Infectious keratitis is a major cause of global blindness. We tested whether standalone photoactivated chromophore corneal cross-linking (PACK-CXL) may be an effective first-line treatment in early to moderate infectious keratitis, compared with standard antimicrobial treatment....

Full description

Bibliographic Details
Main Authors: Farhad Hafezi, Mohammed Hosny, Rohit Shetty, Boris Knyazer, Shihao Chen, Qinmei Wang, Hassan Hashemi, Emilio A. Torres-Netto, the PACK-CXL Working Group
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Eye and Vision
Subjects:
Photoactivated chromophore
Corneal cross-linking
Infectious keratitis
Corneal melting
PACK-CXL
Online Access:https://doi.org/10.1186/s40662-021-00272-0

Similar Items

Similar Items